Physician profile
Marcia MD Liu
NPI 1144294737
$622.10
in general payments reported to CMS, 2019-2025
14 companies · $389 in 2025
The $389 reported for 2025 was less than what a typical Nuclear Cardiology provider received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.81 · 2020: $30.88 · 2022: $45.98 · 2023: $67.53 · 2024: $59.83 · 2025: $389.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $149.88 | 2025 | Wainua, Farxiga |
| Novartis Pharmaceuticals Corporation | $81.67 | 2020-2025 | |
| Pfizer INC. | $81.37 | 2022-2025 | |
| Amgen INC. | $66.25 | 2023-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $43.84 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $35.33 | 2022-2025 | Verquvo |
| Novo Nordisk INC | $31.93 | 2024-2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $28.38 | 2023-2024 | Eliquis |
| Heartflow, INC. | $24.00 | 2025 | |
| Alnylam Pharmaceuticals INC. | $18.16 | 2025 | Onpattro |
| Bridgebio Pharma, INC. | $18.07 | 2025 | Attruby |
| W. L. Gore & Associates, INC. | $15.56 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.85 | 2024 | Jardiance |
| Boston Scientific Corporation | $13.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.